References

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BNAO
September 1, 2018
52(9): 910-919 | McConachie SM, Almadrahi Z, Wahby KA, Wilhelm SM.
Pharmacotherapy in Acutely Anemic Jehovah's Witnesses: An Evidence-Based Review. Ann Pharmacother.
STROKE
May 1, 2018
38(5): 755-766 | Cipolla MJ, Linfante I, Abuchowski A, Jubin R, Chan SL.
Pharmacologically increasing collateral perfusion during acute stroke using a carboxyhemoglobin gas transfer agent (Sanguinate®) in spontaneously hypertensive rats. J Cereb Blood Flow Metab.
STROKE
April 1, 2018
27(4): 313-324 | Tallarico RT, Pizzi MA, Freeman WD.
Investigational drugs for vasospasm after subarachnoid hemorrhage. Expert Opin Investig Drugs.
OTHER
January 1, 2018
32(1) | Abu Jawdeh BG, Woodle ES, Leino AD, Brailey P, Tremblay S, Dorst T, Abdallah MH, Govil A, Byczkowski D, Misra H, Abuchowski A, Alloway RR.
A phase Ib, open-label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end-stage renal disease. Clin Transplant.
STROKE
December 1, 2017
27(3): 341-349 | Dhar R, Misra H, Diringer MN.
SANGUINATE® (PEGylated Carboxyhemoglobin Bovine) Improves Cerebral Blood Flow to Vulnerable Brain Regions at Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage. Neurocrit Care.
BNAO
August 1, 2017
27(4): 300-302 | Sam C, Desai P, Laber D, Patel A, Visweshwar N, Jaglal M.
Pegylated bovine carboxyhaemoglobin utilisation in a thrombotic thrombocytopenic purpura patient. Transfus Med.

Learn how you can be part of the journey

Join us in revolutionizing treatments for severe
and life-threatening conditions